A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT07392866 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07392866
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2030-03-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.